Rise in Prevalence of Airborne Diseases and Increasing Pollution to Propel the Biodetection Market Growth


Biodetection Market
Biodetection Market

Global Biodetection Market, by Type of Product and Services (by Product (Bioanalyses, Instruments, Reagents and Media, and Accessories and Consumables) and by Services (Bioanalyses, Chemical Analyses, and DNA Based Analyses)), by Application (Defence, Food and Environment, and Clinical), and by Region (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2023-2030

According to Coherent Market Insights the Biodetection Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Biodetection is a term that encompasses global strategies for detecting biological threats such as pathogens, infectious diseases, and biological weapons. Biodetection is widely used for diagnosing disease or infection, point-of-care monitoring and treatment, environmental monitoring, forensics and research, and detecting toxins. The use of biodetectors and accessories in point-of-care testing helps in quick detection of analytes near to patients and better disease diagnosis, monitoring, and management. The technology plays a key role in future biomedicine and healthcare.

Competitive Landscape:

Major players operating in the global biodetection market are Smith Group Plc., Cepheid Inc., Agilent Technologies, Roche Diagnostics, BioDetection Systems B.V., and Dycor Technologies Ltd., among others.

Key Market Drivers:

Increasing prevalence of airborne diseases and increasing pollution across the globe is expected to boost growth of the global biodetection market during the forecast period. For instance, as per the World Health Organization (WHO), the combined effects of ambient air pollution and household air pollution are associated with 6.7 million premature deaths annually. Household air pollution exposure leads to noncommunicable diseases such as stroke, ischaemic heart disease, lung cancer, and chronic obstructive pulmonary disease (COPD).

Moreover, misuse of biological agents and weapons across the world is expected to boost growth of the global biodetection market. For instance, according to WHO, biological and toxin weapons are either microorganisms such as virus, bacteria or fungi, or toxic substances produced by living organisms that are produced and released deliberately to cause disease and death in humans, plants, and animals. This in turn is rising the use of biodetection worldwide.

COVID-19 Impact Analysis:

In response to the COVID-19 crisis, demand for biodetectors and accessories significantly soared with increase in regulatory support towards preventive measures and initiating clinical urgency for procuring biodefense mechanisms. For instance, in February 2021, Smiths Detection launched the biological identifier, BioFlash, to detect SARS-CoV-2 (COVID-19) virus in the air following tests performed by the U.S. Army Medical Research Institute of Infectious Diseases (AMRIID). This in turn is driving the growth of the market.

Key Takeaways:

·       The market is expected to exhibit a CAGR of XX % during the forecast period due to the increasing demand for technologically advanced instruments for enhanced and early detection of bio threats. For instance, in January 2023, MeitY launched the Technology for Biosensing system for the detection of Endocrine Disrupting Chemicals in aquatic ecosystems (MEAN) developed under MeitY-supported projects. MeitY developed a biosensing system for detection of Endocrine Disrupting Chemicals (EDC) in aquatic ecosystems, for qualitative and quantitative analysis of EDC content in water bodies.

·       Among regions, Asia Pacific is expected to witness robust growth in the market due to the rise in prevalence of airborne diseases and increasing pollution, misuse of biological agents and weapons, and increase in demand for technologically advanced devices or tools for enhanced and early detection of bio threats in the region.

For instance, India has cautioned over the “heightened” threat of misuse of biological agents and chemicals as weapons against the backdrop of the COVID-19 pandemic and called on the international community to address the rapid evolution of proliferation risks. The access to these weapons of mass destruction by terrorists and other non-state actors adds a serious dimension to threats posed by these weapons to international peace and security, A. Amarnath, a counsellor at India's UN Mission said.

Comments

Popular posts from this blog

Refinery Catalysts are Important Components of a Petroleum Refinery

Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient

Global Flocculant And Coagulant Market Is Estimated To Witness High Growth Owing To Increasing Demand For Water Treatment Applications